Trade Name | Generic name | Relevant Guideline |
---|---|---|
Synthroid | Levothyroxine | AACE 200214 |
Maxalt | Rizatriptan | AAFP/ACP-ASIM 200215 |
Levitra | Vardenafil | ACP 201016 |
Celebrex | Celecoxib | ACR 201217 |
Januvia | Sitagliptin | ADA 201218 |
Actos | Pioglitazone | ADA 201218 |
Cymbalta | Duloxetine | APA 201019 |
Pristiq | Desvenlafaxine | APA 201019 |
Amitiza | Lubiprostone | ASCRS 200720 |
Lovaza | Omega-3-acid ethyl esters | ATP III 200421 |
Crestor | Rosuvastatin | ATP III 200421 |
Lipitor | Atorvastatin | ATP III 200421 |
Trilipix | Fenofibric Acid | ATP III 200421 |
Vytorin | Ezetimibe and simvastatin | ATP III 200421 |
Avodart | Dutasteride | AUA22 |
Savella | Milnacipran | EULAR 200823 |
Spiriva | Tiotropium | GOLD 201024 |
Bystolic | Nebivolol | JNC VII25 |
Micardis | Telmisartan | JNC VII25 |
Diovan | Valsartan | JNC VII25 |
Toviaz | Fesoterodine | NICE 200626 |
Enablex | Darifenacin | NICE 200626 |
Seroquel | Quetiapine | NICE 200627 |
AACE, American Association of Clinical Endocrinologists; AAFP, American Academy of Family Physicians; ACP-ASIM, American College of Physicians-American Society of Internal Medicine; ADA, American Diabetes Association; ACR, American College of Rheumatism; APA, American Psychiatric Association; ASCRS, American Society of Colon and Rectal Surgeons; ATP, Adult Treatment Panel; AUA, American Urologic Association; EULAR, European League Against Rheumatism; GOLD, Global Initiative for Chronic Obstructive Lung Disease; JNC, Joint National Committee; NICE, National Institute for Clinical Excellence (UK).